MARC record from Internet Archive

LEADER: 01916cam 2200385Ka 4500
001 ocm54026869
003 OCoLC
005 20181003032006.0
008 040114s2003 nyua 001 0 eng d
040 $aUSU$beng$cUSU$dOCLCQ$dKLG$dMMU$dOCLCQ$dOCLCO$dOCLCQ
020 $a0971301735
020 $a9780971301733
035 $a(OCoLC)54026869
050 4 $aRC552.S62$bS63 2003
060 4 $aWM 600$bS678 2003
082 04 $a616.8914
245 00 $aSocial anxiety disorder :$bresearch and practice /$c[edited by] Mark H. Pollack, Naomi M. Simon, Michael W. Otto.
260 $aNew York :$bProfessional Pub. Group,$c℗♭2003.
300 $axii, 208 pages :$billustrations, tables ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
500 $a"Sponsored by Wyeth Pharmaceuticals."
504 $aIncludes index (pages 205-208).
505 0 $aSocial anxiety disorder: phenomenology, epidemiology and comorbidity -- Early antecedents of social anxiety disorder: from risk to prevention -- Quality of life in social anxiety disorder -- Cross-cultural aspects of social anxiety disorder: the influence of culture on the expression of mental distress -- Neurobiology of social anxiety disorder -- Considering mechanism of action in the treatment of social anxiety disorder -- Pharmacotherapy of social anxiety disorder: current practice and future promise -- Cognitive-behavioral therapy for social anxiety disorder.
650 0 $aSocial phobia$xPsychology.
650 0 $aAntisocial personality disorders$xPsychology.
650 0 $aInterpersonal relations$xPsychology.
650 12 $aSocial Behavior Disorders$xpsychology.
650 22 $aAntisocial Personality Disorder$xpsychology.
700 1 $aPollack, Mark H.
700 1 $aSimon, Naomi M.
700 1 $aOtto, Michael W.
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 31 OTHER HOLDINGS